PharmTech Talk

July 11th 2023

FDA's approval of Leqembi paves the way for wider coverage of the drug by Medicare and establishes a process for further clinical testing and evaluation of treatments for this widespread, debilitating condition

June 16th 2023

There is concern that debates will delay the five-year reauthorization of PEPFAR under review by Congress.

June 5th 2023

Reimbursement for Alzheimer's medicines still will occur only with the completion of studies to support full FDA approval.

June 5th 2023

FDA has published a new system for providing basic and essential information on patient use of drugs and certain biologic products.